Enzyme aus einem Guss: CRISPR-Cas-Komponenten arbeiten zusammen, um den Schutz vor Viren zu verbessern bionity.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bionity.com Daily Mail and Mail on Sunday newspapers.
What We Know About SARS-CoV-2 One Year Later: Part 2
Sponsored Content by ACROBiosystemsApr 14 2021
The S protein of SARS-CoV had been studied extensively before the SARS-CoV-2 outbreak. Among other structural proteins of SARS-CoV-2, the S protein was discovered to be highly immunogenic and effective at neutralizing antibodies recovered from SARS patients were directed at S protein.
6,7
Research into therapeutics and vaccines against SARS-CoV-2 was focused immediately on the S protein. Although the four structural proteins of the novel SARS-CoV share over 90% in sequence identity with SARS-CoV-2, S protein consisting of S1 and S2 subunits diverged had just 77% sequence similarity.
1
The S1 subunit contains the NTD or the N-terminal domain and Receptor binding domain (RBD), which binds to the human angiotensin-converting enzyme-2 (ACE2) mainly through direct interaction with the receptor-binding motif (RBM).
What We Know About SARS-CoV-2 One Year Later: Part 4 news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
3
1College of Life Science, Fujian Agriculture and Forestry University, Fuzhou, 350002, People’s Republic of China;
2The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, People’s Republic of China;
3Mengchao Med-X Center, Fuzhou University, Fuzhou, 350025, People’s Republic of China;
4Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362001, People’s Republic of China
Correspondence: Gaoxiong Wang
Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Fujian Medical University, Zhongshan North Road 34, Quanzhou, 362001, People’s Republic of China
Tel/Fax +86 591 8370 5927
Zhixiong Cai
The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Xihong Road 312, Fuzhou, Fujian,